-
Citron Research Renews Attack On Express Scripts
Wednesday, December 14, 2016 - 1:23pm | 342Read More...Shares of Express Scripts Holding Company (NASDAQ: ESRX) fell more than 6 percent on Wednesday after the company announced its 2017 financial guidance and hosted a conference call to discuss its outlook. Citron On The Offense Notable short seller Citron Research likened Express Scripts last week as...
-
Shkreli Thinks Raptor Pharmaceutical's Valuation Was Too Low
Monday, September 12, 2016 - 11:01am | 297Read More...Shares of Raptor Pharmaceutical Corp. (NASDAQ: RPTP) were trading higher by more than 20 percent Monday after the company agreed to be acquired by Horizon Pharma PLC (NASDAQ: HZNP) for $800 million, or $9 per share. Speaking as a guest on Monday's Premarket Prep, Martin Shkreli shared his...



